Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
The recent emergence of a novel pandemic influenza A(H1N1) strain in humans exemplifies the rapid and unpredictable nature of influenza virus evolution and the need for effective therapeutics and vaccines to control such outbreaks. However, resistance to antivirals can be a formidable problem as evi...
Main Authors: | Gallen B Triana-Baltzer, Larisa V Gubareva, John M Nicholls, Melissa B Pearce, Vasiliy P Mishin, Jessica A Belser, Li-Mei Chen, Renee W Y Chan, Michael C W Chan, Maria Hedlund, Jeffrey L Larson, Ronald B Moss, Jacqueline M Katz, Terrence M Tumpey, Fang Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2770640?pdf=render |
Similar Items
-
Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
by: Gallen B Triana-Baltzer, et al.
Published: (2009-11-01) -
Studies on sialidases
by: Augustus, Brian W. J.
Published: (1980) -
The Function of Sialidase Revealed by Sialidase Activity Imaging Probe
by: Akira Minami, et al.
Published: (2021-03-01) -
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.
by: Donata De Marco, et al.
Published: (2012-01-01) -
Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity.
by: Christian Nyffenegger, et al.
Published: (2017-01-01)